To inform drug design for COVID-19: Computational determination of interactions between COVID‑19 gene products and structurally diverse natural products and clinical drugs
Responding to COVID‑19 disruptions to blood transfusion services: A data analytics and visualization platform for blood product inventory management during COVID-19